Puretech Health | search
Click here to view Puretech Health news from 60+ newspapers.
Bookmark or Share- Team - Puretech HealthSharon Barber-Lui is a board member and member of the Audit Committee at PureTech. Ms. Barber-Lui has been Chief Financial Officer, North America for Teva Pharmaceuticals since July 2023. Prior to joining Teva, Ms. Barber-Lui was the Senior Vice President of Finance at EQRx. Ms. Barber-Lui previously worked at Merck...
- Programs - Puretech HealthPrograms. PureTech established the underlying programs and platforms that resulted in 28 therapeutic and therapeutic candidates generated from PureTech's R&D engine, including two taken from inception at PureTech to FDA and EU regulatory clearances and a third that has been filed for FDA approval. View our corporate deck.
- PureTech News | PureTech HealthPureTech News | PureTech Health. Press Releases. ALL > Press Release - 2024-04-18. Other. PureTech Health: Notice of Results. Continue. Press Release - 2024-04-16. Wholly Owned Pipeline - LYT-100. Other. PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis. Continue.
- Puretech Health Plc Patent: Treatment of Acute Myeloid LeukemiaPuretech Health‘s patent involves genetically engineered hematopoietic cells with edited genes for treating hematopoietic malignancies like acute myeloid leukemia.The method includes administering cells with reduced CD33 and CD123 expression along with agents targeting these proteins. GlobalData’s report on Puretech Health gives a 360-degree view of the company including its patenting ...
- Puretech HealthPureTech aggregate percentages including all therapeutic candidates advanced through at least Phase 1 by PureTech or its Founded Entities from 2009 onward, using the aforementioned calculation method based on the following individual phase percentages, Phase 1 (78%), Phase 2 (77%), Phase 3 (75%), last reviewed on October 19, 2023; Phase 2 and ...
More
